Order Article Reprints

Han CY, Patten DA, Kim SI, Lim JJ, Chan DW, Siu MKY, Han Y, Carmona E, Parks RJ, Lee C, et al. Nuclear HKII–P-p53 (Ser15) Interaction is a Prognostic Biomarker for Chemoresponsiveness and Glycolytic Regulation in Epithelial Ovarian Cancer. Cancers. 2021; 13(14):3399. https://doi.org/10.3390/cancers13143399

Han, Chae Young, David A. Patten, Se Ik Kim, Jung Jin Lim, David W. Chan, Michelle K. Y. Siu, Youngjin Han, Euridice Carmona, Robin J. Parks, Cheol Lee, and et al. 2021. "Nuclear HKII–P-p53 (Ser15) Interaction is a Prognostic Biomarker for Chemoresponsiveness and Glycolytic Regulation in Epithelial Ovarian Cancer" Cancers 13, no. 14: 3399. https://doi.org/10.3390/cancers13143399

Han, C. Y., Patten, D. A., Kim, S. I., Lim, J. J., Chan, D. W., Siu, M. K. Y., Han, Y., Carmona, E., Parks, R. J., Lee, C., Di, L.-J., Lu, Z., Chan, K. K. L., Ku, J.-L., Macdonald, E. A., Vanderhyden, B. C., Mes-Masson, A.-M., Ngan, H. Y. S., Cheung, A. N. Y., ... Tsang, B. K. (2021). Nuclear HKII–P-p53 (Ser15) Interaction is a Prognostic Biomarker for Chemoresponsiveness and Glycolytic Regulation in Epithelial Ovarian Cancer. Cancers, 13(14), 3399. https://doi.org/10.3390/cancers13143399